Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

RRECURSION PHARMACEUTICALS, INC.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
R

RECURSION PHARMACEUTICALS, INC.

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • News
  • Insider Transactions
Loading insider transactions

Insider transactions

Insider sentiment

Insider transactions

Insider sentiment

SellBuy
DateNameTitleSharesValueTransactionSource
Oct 6, 2026HERSHBERG ROBERTDirector25,000Class A Common Stock—Sell
Oct 6, 2026HERSHBERG ROBERTDirector25,000Class A Common Stock—Option exercise
Oct 6, 2026Borgeson BlakeDirector50,000Class A Common Stock—Sell
Oct 1, 2026Li Dean YDirector3,378Class A Common Stock—Grant / award
Oct 1, 2026Dar ZavainDirector4,607Class A Common Stock—Grant / award
Sep 15, 2026Taylor Ben RChief Financial Officer5,396Class A Common Stock—Tax withholding
Sep 8, 2026Khan NajatCEO and President22,408Class A Common Stock—Sell
Sep 1, 2026Borgeson BlakeDirector30,000Class A Common Stock—Sell
Aug 17, 2026Taylor Ben RChief Financial Officer25,018Class A Common Stock—Tax withholding
Aug 17, 2026Hallett DavidChief Scientific Officer26,657Class A Common Stock—Tax withholding
…
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • Insider Transactions